Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Fry

Showing results (711-720 of 737) with videos related to

Pageof 74
Sort By:
Scientific Reports|June 15, 2023
Visiting nature is associated with lower socioeconomic inequalities in well-being in WalesJoanne K Garrett, Francis M Rowney, Mathew P White, et al.
Nature Reviews. Clinical Oncology|October 1, 2024
Two decades of advances in clinical oncology - lessons learned and future directionsSusana Banerjee, Christopher M Booth, Eduardo Bruera, et al.
The Journal of Clinical Investigation|January 30, 2019
T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapyTori N Yamamoto, Ping-Hsien Lee, Suman K Vodnala, et al.
Med (New York, N.Y.)|March 29, 2024
Icosapent ethyl modulates circulating vascular regenerative cell content: The IPE-PREVENTION CardioLink-14 trialEhab Bakbak, Aishwarya Krishnaraj, Deepak L Bhatt, et al.
Lancet (London, England)|October 17, 2014
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trialDaniel W Lee, James N Kochenderfer, Maryalice Stetler-Stevenson, et al.
Blood Advances|December 18, 2025
10-year experience of CD22 CAR T-cells for children and young adults with B-cell acute lymphoblastic leukemiaAlexandra Dreyzin, Bonnie Yates, Haneen N Shalabi, et al.
Molecular Cancer Therapeutics|February 26, 2021
Robust Antitumor Activity and Low Cytokine Production by Novel Humanized Anti-CD19 CAR T CellsAlka Dwivedi, Atharva Karulkar, Sarbari Ghosh, et al.
Life Sciences in Space Research|May 14, 2018
Solar particle event storm shelter requirements for missions beyond low Earth orbitL W Townsend, J H Adams, S R Blattnig, et al.
The Journal of Experimental Medicine|June 25, 2008
Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsetsClaude Sportès, Frances T Hakim, Sarfraz A Memon, et al.
JCI Insight|June 9, 2026
Reduced CCL/Be-specific CD4+ T cells in CCL3-deficient or peptide-MHC II CAR-T cell-treated miceMichael T Falta, Masoom Raza, Caley J Nevienski, et al.
Pageof 74

Showing results (711-720 of 737) with videos related to

Sort By:
Pageof 74
Scientific Reports|June 15, 2023
Visiting nature is associated with lower socioeconomic inequalities in well-being in WalesJoanne K Garrett, Francis M Rowney, Mathew P White, et al.
Nature Reviews. Clinical Oncology|October 1, 2024
Two decades of advances in clinical oncology - lessons learned and future directionsSusana Banerjee, Christopher M Booth, Eduardo Bruera, et al.
The Journal of Clinical Investigation|January 30, 2019
T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapyTori N Yamamoto, Ping-Hsien Lee, Suman K Vodnala, et al.
Med (New York, N.Y.)|March 29, 2024
Icosapent ethyl modulates circulating vascular regenerative cell content: The IPE-PREVENTION CardioLink-14 trialEhab Bakbak, Aishwarya Krishnaraj, Deepak L Bhatt, et al.
Lancet (London, England)|October 17, 2014
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trialDaniel W Lee, James N Kochenderfer, Maryalice Stetler-Stevenson, et al.
Blood Advances|December 18, 2025
10-year experience of CD22 CAR T-cells for children and young adults with B-cell acute lymphoblastic leukemiaAlexandra Dreyzin, Bonnie Yates, Haneen N Shalabi, et al.
Molecular Cancer Therapeutics|February 26, 2021
Robust Antitumor Activity and Low Cytokine Production by Novel Humanized Anti-CD19 CAR T CellsAlka Dwivedi, Atharva Karulkar, Sarbari Ghosh, et al.
Life Sciences in Space Research|May 14, 2018
Solar particle event storm shelter requirements for missions beyond low Earth orbitL W Townsend, J H Adams, S R Blattnig, et al.
The Journal of Experimental Medicine|June 25, 2008
Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsetsClaude Sportès, Frances T Hakim, Sarfraz A Memon, et al.
JCI Insight|June 9, 2026
Reduced CCL/Be-specific CD4+ T cells in CCL3-deficient or peptide-MHC II CAR-T cell-treated miceMichael T Falta, Masoom Raza, Caley J Nevienski, et al.
Pageof 74